Kevin Loring Winthrop

Oregon Health & Science University

NIH Rank #2964
  • Program Leader
  • R01 Holder
  • Early Career

NIH Funding · FY2024

Total Funding
$2.8M
Fiscal year 2024
Grants Awarded
3
Active NIH grants
National Rank
#2,964
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.8M across 3 grants · National rank #2964.

Top grants by award amount

Kevin Loring Winthrop's NIH grant portfolio, ranked by award amount.

  • 5U01DC020175-03U01
    Phase 2 Study of the Efficacy and Safety of ORC-13661 for the Prevention of Ototoxicity in Patients Receiving Intravenous Amikacin for Treatment of Non-Tuberculous Mycobacterium Infection
    $1.1M
    award amount
  • 1R01AI175935-01A1R01
    Mycobacterium avium complex pulmonary infection: immunologic and transcriptomic signatures of disease and treatment response
    $873.2K
    award amount
  • 1R01AI177986-01A1R01
    CRISPR detection of circulating cell-free Mycobacterium avium complex (MAC) DNA for rapid diagnosis and monitoring of MAC pulmonary disease
    $866.9K
    award amount

Affiliation

Institutions that have administered grants for Kevin Loring Winthrop.

Affiliated with Oregon Health & Science University (OR).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Oregon Health & Science University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #2964
  6. 2024
    Entered Top 25% Nationally
    Ranked #2964